Lenskart shares rise 2% after Q4 profit slips; revenue jumps 46% YoY

Shares of Lenskart climbed by 2% on Thursday, despite a 9% decline in net profit for the fourth quarter. The company showcased impressive operational growth, with a significant 46% increase in revenue. Lenskart has intensified its eye testing services and is ambitiously spreading its footprint into new cities, while its international ventures are thriving.

Positive Breakout: These 7 stocks cross above their 200 DMAs

In the Nifty500 pack, seven stocks’ closing prices crossed above their 200 DMA (Daily Moving Averages) on May 20, 2026, according to stockedge.com’s technical scan data. The 200-day daily moving average (DMA) is used by traders as a key indicator for determining the overall trend in a particular stock. As long as the stock is […]

LIC to announce Q4 results today: Here’s what to expect from the insurance behemoth

Life Insurance Corp (LIC) is poised to reveal its March quarter earnings today. Investors are keenly awaiting insights into new business growth, profit margins, and market share trends amidst escalating competition. Brokerages anticipate robust premium growth, driven by a favorable product mix and a strategic shift towards non-participating policies, signaling a positive outlook for the […]

Sebi sends show cause notice to 6 Capital Group FPIs

India’s market regulator Sebi has issued a show cause notice to six Capital Group FPIs for alleged lapses in trade confidentiality. Two traders reportedly shared sensitive order details with Singapore-based Rohit Salgaocar, who then allegedly passed them to market operator Ketan Parekh. This enabled a front-running network to profit from illicit gains.

Global Market Today: Asian stocks rise on Iran optimism, Nvidia slips

Asian equities surged, mirroring Wall Street’s gains as optimism surrounding US-Iran talks eased Middle East tensions. Crude oil and bond yields declined, while South Korean stocks and Samsung Electronics saw significant increases. Despite a general market rebound, Nvidia’s shares experienced a slight dip following its sales forecast.

Cenexi recovery, new product launches and capacity additions power Gland Pharma outlook

Gland Pharma stock surged to a 52-week high following robust March quarter and full-year results. Its European unit, Cenexi, is improving profitability. Future growth is anticipated from capacity expansions and new product lines. The company’s contract development and manufacturing business is also expanding. Investors are watching Gland Pharma’s growth prospects.

Parle Industries hits upper circuit amid ‘Melody’ confusion

Dalal Street saw a peculiar event where investors confused Parle Industries with the original Parle candy maker. A social media video led to a surge in Parle Industries’ stock. This mix-up highlights a recurring investor behavior. Similar incidents have occurred with other companies, demonstrating a pattern of name-based trading errors.

Eurobank enables Greece-India UPI remittances

Eurobank is launching a new service for cross-border remittances from Greece and Cyprus to India using UPI. This marks the first time a European bank offers this facility. The bank is also opening a representative office in Mumbai to boost trade and investment between India and the EU.